Clinical Trials
2 trialsNCT05400876 2023-02-14
To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT05680038 2023-01-11
Penpulimab in Maintenance Therapy in Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Unknown